Article

Transitions, Zeiss Vision team for eye-care education tour

Pinellas Park, FL-Transitions Optical Inc. has teamed with Carl Zeiss Vision for a 21-city U.S. tour that will allow eye-care professionals to learn about vision-care products and healthy sight while earning ABO or COPE continuing education credits.

Pinellas Park, FL-Transitions Optical Inc. has teamed with Carl Zeiss Vision for a 21-city U.S. tour that will allow eye-care professionals to learn about vision-care products and healthy sight while earning ABO or COPE continuing education credits.

The national Transitions and Carl Zeiss Vision Tour, which kicked off June 14 and continues through October, is themed "The Power of Partnership3 ." The title denotes an alliance among Transitions, Carl Zeiss Vision, and the customer as a powerful trio.

Tour stops will begin with a dinner buffet and cocktails followed by two 1-hour seminars that explore significant topics related to eye health issues. Speakers from the Transitions and Carl Zeiss Vision teams will present COPE-approved seminars and ABO-accredited courses during the tour.

The balance of the Transitions and Carl Zeiss Vision Tour is scheduled to be in these markets:

July 19 – Atlanta
July 20 – Knoxville, TN
Aug. 8 – Louisville, KY
Aug. 9 – Cincinnati
Aug. 10 – Charlotte, NC
Aug. 16 – Pittsburgh
Sept. 9 – Denver
Sept. 21 – Seattle
Sept. 27 – Baltimore
Sept. 28 – Richmond, VA
Oct. 18 – Houston and Phoenix
Oct. 19 – San Antonio, Kansas City, KS, and Greenville, SC
TBD – Minneapolis

For more information, call Transitions Optical Customer Service at 800/848-1506 or register online at http://www.transitions.com/seminars/.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.